Treatment of functional dyspepsia with antianxiety or antidepressive agents: Systematic review

Journal of Gastroenterology

Volumn 40, Issue 11, 2005, Pages 1036-1042

  Hojo, Mariko ^a   Miwa, Hiroto ^b   Yokoyama, Tetsuji ^c   Ohkusa, Toshifumi ^a   Nagahara, Akihito ^a   Kawabe, Masato ^a   Asaoka, Daisuke ^a   Izumi, Yuko ^a   Sato, Nobuhiro ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Chlordiazepoxide; Levosulpiride; Mianserin

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CHLORDIAZEPOXIDE; CLOMIPRAMINE; CLONAZEPAM; DESIPRAMINE; DIAZEPAM; DOSULEPIN; DOXEPIN; ESTAZOLAM; FLUOXETINE; FLURAZEPAM; FLUVOXAMINE; IMIPRAMINE; LOFEPRAMINE; LORAZEPAM; MIANSERIN; MILNACIPRAN; MIRTAZAPINE; OXAZEPAM; PAROXETINE; QUAZEPAM; SERTRALINE; TEMAZEPAM; TRAZODONE; TRIAZOLAM; UNINDEXED DRUG; VENLAFAXINE;

CLINICAL TRIAL; CONFIDENCE INTERVAL; DRUG EFFICACY; DYSPEPSIA; HUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH EMPTYING; SYSTEMATIC REVIEW;

ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; DYSPEPSIA; HUMANS; TREATMENT OUTCOME;

EID: 30344435951     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-005-1687-8     Document Type: Review

References (35)

1. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999;45 (Suppl 2):II37-42 10457043
2. Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: Results from the domestic/international gastroenterology surveillance study (DIGEST). Scand J Gastroenterol 1999;34 (Suppl 231):20-8
3. Kawamura A, Adachi K, Takashima T, Murao M, Katsube T, Yuki M, Prevalence of functional dyspepsia and its relationship with Helicobacter pylori infection in a Japanese population. J Gastroenterol Hepatol 2001;16 384-8. 11354275 1:STN:280:DC%2BD3M3lsF2qtw%3D%3D
4. Fisher RS, Parkman HP, Management of nonulcer dyspepsia. N Engl J Med 1998 339 1376-81 9801400 1:STN:280:DyaK1M%2Fgs1Kjsg%3D%3D
5. Jackson JL, O'Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K. Treatment of functional gastrointestinal disorders with antidepressant medications: A meta-analysis. Am J Med 2000;108:65-72 11059442 1:CAS:528:DC%2BD3cXptlektQ%3D%3D
6. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22 719-48 13655060 1:STN:280:CyaD1cvnt1M%3D
7. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986;7:177-88 3802833 1:STN:280:BiiC3cvisFI%3D
8. Breslow NE, Day NE. Statistical methods in cancer research, volume II: the design and analysis of cohort studies, IARC Scientific publications, no 82. New York: Oxford University Press; 1994
9. Baume P, Cuthbert J. The effect of medazepam in relieving symptoms of functional gastrointestinal distress. Aust N Z J Med 1973;3; 457-60 4591119 1:STN:280:CSuD1MnhtVA%3D
10. Mertz H, Fass R, Kodner A, Yan-Go F, Fullerton S, Mayer EA. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998;93:160-5 9468233 1:CAS:528:DyaK1cXmt1GrsrY%3D
11. Tanum L, Malt UF. A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin. Scand J Gastroenterol 1996;31:318-25 8726297 1:CAS:528:DyaK28XislKmtr8%3D
12. Lordrup D, Langemark M, Hansen HJ, Olesen J, Bech P. Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study Psychopharmacology (Berl) 1989;99:1-7
13. Wu CY, Chou LT, Chen HP, Chang CS, Wong PG, Chen GH. Effect of fluoxetine on symptoms and gastric dysrhythmia in patients with functional dyspepsia. Hepatogastroenterology 2003;50: 278-83 12630041
14. Distrutti E, Fiorucci S, Hauer SK, Pensi MO, Vanasia M, Morelli A. Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. Aliment Pharmacol Ther 2002;16 613-22 11876717 1:CAS:528:DC%2BD38XivV2ltbc%3D
15. Mansi C, Borro P, Giacomini M, Biagini R, Mele MR, Pandolfo N. et al. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther 2000;14:561-9 10792119 1:CAS:528:DC%2BD3cXjvFSgs7c%3D
16. Song CW, Chun HJ, Kim CD, Ryu HS, Choe JG, Hyun JH. Effects of levosulpiride in patients with functional dyspepsia accompanied by delayed gastric emptying Korean. J Intern Med 1998;13:15-21 9538626 1:STN:280:DyaK1c7pvFCmsA%3D%3D
17. Arienti V, Corazza GR, Sorge M, Boriani M, Ugenti F, Biagi F. The effects of levosulpiride on gastric and gall-bladder emptying in functional dyspepsia. Aliment Pharmacol Ther 1994;8:631-8 7734028 1:STN:280:ByqB3M%2Fks1E%3D
18. Corazza GR, Biagi F, Albano O, Porro GB, Cheli R, Mazzacca G. Levosulpiride in functional dyspepsia: A multicentric, double-blind, controlled trial. Ital J Gastroenterol 1996-28 317-23 8891846 1:CAS:528:DyaK28XmvFKmtb8%3D
19. McHardy G, Sekinger D, Balart L, Cradic HE. Chlordiazepoxide-clidinium bromide in gastrointestinal disorders: Controlled clinical studies. Gastroenterology 1968;54:508-13
20. Deutsch EM. Relief of anxiety and related emotions in patients with gastrointestinal disorders. A double-blind controlled study. Am J Dig Dis 1971;16:1091-4 4944409 1:STN:280:CS2D1cjkslY%3D
21. K Mine F Kanazawa M Hosoi N Kinukawa C Kubo 1998 Treating nonulcer dyspepsia considering both functional disorders of the digestive system and psychiatric conditions. Dig Dis Sci 43 1241-7 9635614 1:STN:280:DyaK1c3pslGgtQ%3D%3D
22. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterol Int 1991;4:145-60
23. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelad JR, Tytgat GNJ. Functional gastroduodenal disorders. Gut 1999;45 (Suppl II): II37-II42 10457043
24. Talley NJ. Review article: Functional dyspepsia-should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995;9: 107-15 7605850 1:STN:280:ByqA38blsVE%3D
25. Miwa H, Hirai S, Nagahara A, Murai T, Nishira T, Kikuchi S. Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients - a double-blind placebo-controlled study. Aliment Pharmacol Ther 2000;14:317-24 10735925 1:STN:280:DC%2BD3c3gtVOjsg%3D%3D
26. Moayyedi P, Soo S, Deeks J, Forman D, Harris A, Innes M. Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther 2003;17:1215-27 12755835 1:CAS:528:DC%2BD3sXltleis7w%3D
27. Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A. Efficacy of omeprazole in functional dyspepsia: Double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998;12:1055-65 9845395 1:CAS:528:DyaK1cXotVeruro%3D
28. Erckenbrecht JF, Schafer R, Kohler G, Enck P. Dyspeptic symptoms in healthy volunteers with stress are related to stress-induced increase of anxiety-results of prospective study with a longterm "physiological" stress model. J Gastrointest Motility 1993;5:189
29. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ. 3rd. Dyspepsia and dyspepsia subgroups: A population-based study. Gastroenterology 1992;102:1259-68 1551533 1:STN:280:By2B3c7ls1A%3D
30. Konekes K, Jackson JL, Chamberlin J. Depressive and anxiety disorders in patients presenting with physical complaints: Clinical predictors and outcome. Am J Med 1997;103:339-47
31. Rossi F, Forgione A. Pharmacotoxicological aspects of levosulpiride. Pharmacol Res 1995;31 81-94 7596959 1:CAS:528:DyaK2MXmtVWgurc%3D
32. Nagahata Y, Azumi Y, Kawakita N, Wada T, Saitoh Y. Inhibitory effect of dopamine on gastric motility in rats. Scand J Gastroenterol 1995;30: 880-5 8578187 1:CAS:528:DyaK2MXpsFait7c%3D
33. Bocchetta A, Bernardi F, Burrai C, Pedditzi M, Del Zompo MA. A double-blind study of l-sulpiride versus amitriptyline in lithium-maintained bipolar depressives. Acta Psychiatr Scand 1993;88: 434-9 8310852 1:STN:280:ByuC2cvjvVI%3D
34. Koran LM, McElroy SL, Davidson JR, Rasmussen SA, Hollander E, Jenike MA. Fluvoxamine versus clomipramine for obsessive-compulsive disorder: A double-blind comparison. J Clin Psychopharmacol 1996;16: 121-9 8690827 1:CAS:528:DyaK2sXntVartro%3D
35. Kiev A, Feiger A. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients. J Clin Psychiatry 1997;58:146-52 9164424 1:CAS:528:DyaK2sXjsVyit7w%3D